The Top Key Players in the Non-Invasive Prenatal Testing Market and Their Shares in the Global Markets

Global non-invasive prenatal testing market accounted for over USD 1.75 billion in 2017 and is expected to grow at a CAGR of 18.37% during the forecast period, 2019–2026.

The Global Non-Invasive Prenatal Testing Market Report Offers Business Outlook, Upcoming Emerging Market Trends, Latest Technology, Industry Challenges, And Forecast 2021-2029.

The Non Invasive Prenatal Testing Market research presents a study by combining primary as well as secondary research. The report gives visions into the key factors concerned with producing and limiting Non Invasive Prenatal Testing market growth.

The report also tracks the latest market restraints, such as driving factors, restraining factors, and industry news like mergers, acquisitions, and investments. It offers market size, market share, growth rate by types, applications, and syndicates both qualitative and measurable methods to make micro and macro forecasts in different regions or countries.

Major Points Covered in this Report:

• Market Overview:
• Key findings
• Introduction
• SWOT Analysis
• Market Size and Trends

Non-Invasive Prenatal Testing Market Segment by Manufacturers includes:
Thermo Fisher Scientific, Illumina, Inc, F. Hoffmann-La Roche Ltd, Pacific Biosciences of California, QIAGEN N.V., PerkinElmer, Inc, Agilent Technologies, Inc., Beijing Genomics Institute, Koninklijke Philips N.V., and GE Healthcare.

The rising number of maternal age, increase in the number of working women in developing economies and various other factors leading to genetic abnormalities in newborn are increasing the market penetration around the world. In addition, rising awareness about these conditions, increasing research and development activities by major players, and increasing government programs in developing economies to reduce the number of genetic abnormalities are further augmenting the market.

Request a Sample PDF Copy of the Report @

Additionally, the report also studies competitive developments, such as mergers and acquisitions, new businesses, new contracts, and new product developments in the global Non Invasive Prenatal Testing industries. The past trends and future predictions included in this report make it highly understandable for the analysis of the market. Moreover, the latest trends, product portfolio, demographics, geographical segmentation, and regulatory framework of the Non Invasive Prenatal Testing markets have also been included in the study.

Market Segmentation:

By Product, Consumables, Instruments

By Method, Ultrasound Detection, Biochemical Screening Tests, Cell-Free DNA in Maternal Plasma Tests, Fetal Cells in Maternal Blood Tests

By Application, Trisomy, Microdeletion Syndrome, Other Applications

By End User, Diagnostic Laboratories, Hospitals

This Report Focuses on Non Invasive Prenatal Testing in the Global Non Invasive Prenatal Testing Market, Especially In:

• North America (USA, Canada, and Mexico)
• Europe (Germany, France, UK, Russia, and Italy)
• Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)
• South America, Middle East, and Africa.

Regional Market Analysis:

• Industry Overview
• Company Profiles
• Synopsis
• Market Research

Key Questions Talked by the Report:

• What is the current size of the overall Non Invasive Prenatal Testing Market?
• To what extent did Covid-19 impact Non Invasive Prenatal Testing Market in 2021?
• What are the main drivers and restraints in the Non Invasive Prenatal Testing Market?
• How is the Non Invasive Prenatal Testing Market anticipated to evolve during the forecast period 2021 – 2029?

Browse Full Report @

About StraitsResearch is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.

Our reports area unit single-point solutions for businesses to grow, evolve, and mature. Our period information assortment strategies in conjunction with the ability to trace quite a million high-growth niche merchandise area units aligned together with your aims.

For More Details, Please Contact us:
Address: 825 3rd Avenue, New York, NY, USA, 10022
Tel: +1 6464807505, +44 203 318 2846

Back to top button